What is Jefferies's price target for INO?

Jefferies's latest stated price target for Inovio Pharmaceuticals Inc. (INO) is $3, from its action on Aug 13, 2026.

What is Jefferies's rating on INO?

Jefferies rates INO Buy, a bullish rating, as of Aug 13, 2026.

When did Jefferies last change its view on INO?

On Aug 13, 2026, Jefferies upgrades to Buy from Hold, price target $3.

Jefferies INO price target and rating history

Inovio Pharmaceuticals Inc. (INO) · Health Care

Jefferies rates Inovio Pharmaceuticals Inc. (INO) Buy with a $3 price target, as of its latest action on Aug 13, 2026. It has published 3 rating actions on INO since June 2021, including 1 upgrade and 0 downgrades.

Current rating: Buy
Price target: $3
Median target, all firms: Too few
Actions on INO: 3

Jefferies price target on INO

Jefferies price target on INO, each point a stated target, June 2021 to August 2026.

Every Jefferies rating on INO

Aug 13, 2026
UpgradeJefferies upgrades to Buy from Hold, price target $3
Dec 29, 2021
ResumeJefferies resumes coverage at Hold, price target $8 to $6
Jun 24, 2021
InitiateJefferies starts coverage at Hold, price target $9

How other firms rate INO

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
H.C. Wainwright	Buy	$5	Nov 2, 2026
Jefferies	Buy	$3	Aug 13, 2026

Questions about Jefferies and INO

What is Jefferies's price target for INO?: Jefferies's latest stated price target for Inovio Pharmaceuticals Inc. (INO) is $3, from its action on Aug 13, 2026.
What is Jefferies's rating on INO?: Jefferies rates INO Buy, a bullish rating, as of Aug 13, 2026.
When did Jefferies last change its view on INO?: On Aug 13, 2026, Jefferies upgrades to Buy from Hold, price target $3.

More INO rating histories

All Jefferies ratings INO news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.